Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
-815K
-
Total reported value, excl. options
-
$770M
-
Value change
-
-$29.2M
-
Put/Call ratio
-
0.7
-
Number of buys
-
67
-
Number of sells
-
-90
-
Price
-
$27.52
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q3 2020
198 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q3 2020.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 51.1M outstanding shares and own 54.68% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.66M shares), VANGUARD GROUP INC (3.25M shares), Redmile Group, LLC (2.23M shares), STATE STREET CORP (2.14M shares), JPMORGAN CHASE & CO (1.99M shares), DIMENSIONAL FUND ADVISORS LP (685K shares), UBS Group AG (662K shares), GOLDMAN SACHS GROUP INC (533K shares), Aquilo Capital Management, LLC (511K shares), and GEODE CAPITAL MANAGEMENT, LLC (493K shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.